Compare MasterCard Inc (MA) vs Tempus AI (TEM) Price & Performance

Mastercard (MA) trades at $539.26, down 0.8% on the day, with strong technical momentum and bullish analyst sentiment. The stock demonstrates robust fundamentals with consistent earnings beats, including Q1 2026 EPS of $4.60 beating expectations of $4.41. Revenue growth accelerated to $32.79B in 2025 with impressive 45.88% net margins. Recent institutional buying activity and a $0.87 dividend declaration for August 2026 reflect confidence in the company's financial health.

Outlook remains positive with 79% analyst buy ratings and $634.27 consensus price target representing 18% upside. Key opportunities include expanding digital payment adoption and AI integration in ASEAN markets. Risks include payment disruption from stablecoins and competitive threats. The stock trades at premium valuations (P/E 31.68) but justifies this with superior profitability (ROE 232.56%) and consistent execution.

Tempus AI (TEM) trades at $48.41, down 7.74% in the last 24 hours, reflecting a bearish technical signal. The company reported revenue of $1.27 billion in 2025 but a net loss of $245.03 million, with negative profitability metrics. Recent news highlights growth in AI-driven diagnostics and data services, including FDA approvals and research collaborations. The stock is trading well below the analyst consensus price target of $68.50, with a majority of analysts maintaining a Buy rating.

The outlook for TEM is a mix of high growth potential in healthcare AI and significant financial risk due to persistent losses. Investment opportunity lies in its proprietary data platform and expanding market reach, but risks include execution challenges and cash burn. Wall Street sentiment remains positive on long-term prospects, but investors should weigh the volatility against the company's unproven path to profitability.